c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EDT
UTC-4 New York
Blue Chip
Log in
Sign up
CLVS
Clovis Oncology, Inc.
stock
NASDAQ
Inactive
Dec 20, 2022
0.0812
USD
-5.581%
(-0.0048)
24,516,461
Pre-market
After-hours
Overview
Company
Exchanges
Shorts
News
News
CLVS News
1
/
1
Oct 16, 2026
Day breaks
Oct 16, 2026
07:30 AM EDT
Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development
·
PR Newswire